Cross-talk between the estrogen receptor-, protein kinase A-, and mitogen-activated protein kinase-mediated signaling pathways in the regulation of lactotroph proliferation in primary culture

Journal of Steroid Biochemistry and Molecular Biology

Volumn 88, Issue 2, 2004, Pages 123-130

  Yamakawa, Koji ^a   Arita, Jun ^a  

^a UNIVERSITY OF YAMANASHI   (Japan)

Author keywords

Antiestrogen; Cross talk; Estradiol; Estrogen receptor; Lactotroph; Mitogen activated protein kinase; Proliferation; Protein kinase A

Indexed keywords

4 HYDROXYTAMOXIFEN; ANTIESTROGEN; ANTIGESTAGEN; CYCLIC AMP DEPENDENT PROTEIN KINASE; ESTRADIOL; ESTROGEN RECEPTOR; FORSKOLIN; FULVESTRANT; INSULIN; KT 5720; MITOGEN ACTIVATED PROTEIN KINASE; N [2 (4 BROMOCINNAMYLAMINO)ETHYL] 5 ISOQUINOLINESULFONAMIDE; PROLACTIN; PROTEIN KINASE C INHIBITOR;

ANIMAL CELL; ARTICLE; CELL CULTURE; CELL PROLIFERATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; CROSS COUPLING REACTION; FEMALE; HORMONE RESPONSE; MOLECULAR DYNAMICS; MOLECULAR INTERACTION; MOLECULAR MECHANICS; NONHUMAN; RAT; REACTION ANALYSIS; SIGNAL TRANSDUCTION;

ANIMALS; CELL DIVISION; CELLS, CULTURED; CYCLIC AMP-DEPENDENT PROTEIN KINASES; ENZYME INHIBITORS; ESTRADIOL; FEMALE; FORSKOLIN; GENE EXPRESSION REGULATION; INSULIN; MAP KINASE SIGNALING SYSTEM; PITUITARY GLAND, ANTERIOR; PROGESTERONE; PROLACTIN; RATS; RATS, WISTAR; RECEPTOR CROSS-TALK; RECEPTORS, ESTROGEN; SIGNAL TRANSDUCTION;

EID: 1842735414     PISSN: 09600760     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jsbmb.2003.11.003     Document Type: Article

References (56)

1. Wiklund J., Wertz N., Gorski J. A comparison of estrogen effects on uterine and pituitary growth and prolactin synthesis in F344 and Holtzman rats. Endocrinology. 109:1981;1700-1707.
2. Lieberman M.E., Maurer R.A., Claude P., Gorski J. Prolactin synthesis in primary cultures of pituitary cells: regulation by estradiol. Mol. Cell. Endocrinol. 25:1982;277-294.
3. Sarkar D.K., Kim K.H., Minami S. Transforming growth factor-β 1 messenger RNA and protein expression in the pituitary gland: its action on prolactin secretion and lactotropic growth. Mol. Endocrinol. 6:1992;1825-1833.
4. Yin P., Kawashima K., Arita J. Direct actions of estradiol on the anterior pituitary gland are required for hypothalamus-dependent lactotrope proliferation and secretory surges of luteinizing hormone but not of prolactin in female rats. Neuroendocrinology. 75:2002;392-401.
5. Sarkar D.K., Gottschall P.E., Meites J. Damage to hypothalamic dopaminergic neurons is associated with development of prolactin-secreting pituitary tumors. Science. 218:1982;684-686.
6. Demarest K.T., Riegle G.D., Moore K.E. Long-term treatment with estradiol induces reversible alterations in tuberoinfundibular dopaminergic neurons: a decreased responsiveness to prolactin. Neuroendocrinology. 39:1984;193-200.
7. Hashi A., Mazawa S., Chen S.Y., Yamakawa K., Kato J., Arita J. Estradiol-induced diurnal changes in lactotroph proliferation and their hypothalamic regulation in ovariectomized rats. Endocrinology. 137:1996;3246-3252.
8. Hentges S., Sarkar D.K. Transforming growth factor-β regulation of estradiol-induced prolactinomas. Front. Neuroendocrinol. 22:2001;340-363.
9. Spady T.J., McComb R.D., Shull J.D. Estrogen action in the regulation of cell proliferation, cell survival, and tumorigenesis in the rat anterior pituitary gland. Endocrine. 11:1999;217-233.
10. Brunet N., Rizzino A., Gourdji D., Tixier-Vidal A. Effects of thyroliberin (TRH) on cell proliferation and prolactin secretion by GH3/B6 rat pituitary cells: a comparison between serum-free and serum-supplemented media. J. Cell. Physiol. 109:1981;363-372.
11. Prysor-Jones R.A., Silverlight J.J., Jenkins J.S. Oestradiol, vasoactive intestinal peptide and fibroblast growth factor in the growth of human pituitary tumour cells in vitro. J. Endocrinol. 120:1989;171-177.
12. Ben-Jonathan N., Hnasko R. Dopamine as a prolactin (PRL) inhibitor. Endocrinol. Rev. 22:2001;724-763.
13. Lloyd H.M., Meares J.D., Jacobi J. Effects of oestrogen and bromocryptine on in vivo secretion and mitosis in prolactin cells. Nature. 255:1975;497-498.
14. Melmed S. Bromocriptine inhibits colony formation by rat pituitary tumor cells in a double-layered agar clonogenic assay. Endocrinology. 109:1981;2258-2260.
15. Arita J., Hashi A., Hoshi K., Mazawa S., Suzuki S. D2 dopamine-receptor-mediated inhibition of proliferation of rat lactotropes in culture is accompanied by changes in cell shape. Neuroendocrinology. 68:1998;163-171.
16. Suzuki S., Yamamoto I., Arita J. Mitogen-activated protein kinase-dependent stimulation of proliferation of rat lactotrophs in culture by 3′,5′-cyclic adenosine monophosphate. Endocrinology. 140:1999;2850-2858.
17. Ray D., Melmed S. Pituitary cytokine and growth factor expression and action. Endocrinol. Rev. 18:1997;206-228.
18. Sarkar D.K., Hentges S.T., De A., Reddy R.H.R. Hormonal control of pituitary prolactin-secreting tumors. Front. Biosci. 3:1998;d934-d943.
19. Dickson R.B., Lippman M.E. Growth factors in breast cancer. Endocrinol. Rev. 16:1995;559-589.
20. Smith C.L. Cross-talk between peptide growth factor and estrogen receptor signaling pathways. Biol. Reprod. 58:1998;627-632.
21. Yee D., Lee A.V. Crosstalk between the insulin-like growth factors and estrogens in breast cancer. J. Mammary Gland Biol. Neoplasia. 5:2000;107-115.
22. Kawashima K., Yamakawa K., Arita J. Involvement of phosphoinositide-3- kinase and p70 S6 kinase in regulation of proliferation of rat lactotrophs in culture. Endocrine. 13:2000;385-392.
23. Roger P.P., Reuse S., Maenhaut C., Dumont J.E. Multiple facets of the modulation of growth by cAMP. Vitam. Horm. 51:1995;59-191.
24. Watters J.J., Chun T.Y., Kim Y.N., Bertics P.J., Gorski J. Estrogen modulation of prolactin gene expression requires an intact mitogen-activated protein kinase signal transduction pathway in cultured rat pituitary cells. Mol. Endocrinol. 14:2000;1872-1881.
25. Kievit P., Lauten J.D., Maurer R.A. Analysis of the role of the mitogen-activated protein kinase in mediating cyclic-adenosine 3′,5′-monophosphate effects on prolactin promoter activity. Mol. Endocrinol. 15:2001;614-624.
26. Kawashima K., Yamakawa K., Takahashi W., Takizawa S., Yin P., Sugiyama N., Kanba S., Arita J. The estrogen-occupied estrogen receptor functions as a negative regulator to inhibit cell proliferation induced by insulinl/IGF-1: a cell context-specific antimitogenic action of estradiol on rat lactotrophs in culture. Endocrinology. 143:2002;2750-2758.
27. Chijiwa T., Mishima A., Hagiwara M., Sano M., Hayashi K., Inoue T., Naito K., Toshioka T., Hidaka H. Inhibition of forskolin-induced neurite outgrowth and protein phosphorylation by a newly synthesized selective inhibitor of cyclic AMP-dependent protein kinase, N-[2-(p-bromocinnamylamino)ethyl]-5- isoquinolinesulfonamide (H-89), of PC12D pheochromocytoma cells. J. Biol. Chem. 265:1990;5267-5272.
28. Nawaz Z., Stancel G.M., Hyder S.M. The pure antiestrogen ICI182780 inhibits progestin-induced transcription. Cancer Res. 59:1999;372-376.
29. Vegeto E., Allan G.F., Schrader W.T., Tsai M.J., McDonnell D.P., O'Malley B.W. The mechanism of RU486 antagonism is dependent on the conformation of the carboxy-terminal tail of the human progesterone receptor. Cell. 69:1992;703-713.
30. Kobayashi E., Nakano H., Morimoto M., Tamaoki T. Calphostin C (UCN-1028C), a novel microbial compound, is a highly potent and specific inhibitor of protein kinase C. Biochem. Biophys. Res. Commun. 159:1989;548-553.
31. Aronica S.M., Katzenellenbogen B.S. Stimulation of estrogen receptor-mediated transcription and alteration in the phosphorylation state of the rat uterine estrogen receptor by estrogen, cyclic adenosine monophosphate, and insulin-like growth factor-I. Mol. Endocrinol. 7:1993;743-752.
32. Bunone G., Briand P.A., Miksicek R.J., Picard D. Activation of the unliganded estrogen receptor by EGF involves the MAP kinase pathway and direct phosphorylation. EMBO J. 15:1996;2174-2183.
33. Cho H., Aronica S.M., Katzenellenbogen B.S. Regulation of progesterone receptor gene expression in MCF-7 breast cancer cells: a comparison of the effects of cyclic adenosine 3′,5′-monophosphate, estradiol, insulin-like growth factor-I, and serum factors. Endocrinology. 134:1994;658-664.
34. Szego C.M., Davis J.S. Adenosine 3′,5′-monophosphate in rat uterus: acute elevation by estrogen. Proc. Natl. Acad. Sci. U.S.A. 58:1967;1711-1718.
35. Aronica S.M., Kraus W.L., Katzenellenbogen B.S. Estrogen action via the cAMP signaling pathway: stimulation of adenylate cyclase and cAMP-regulated gene transcription. Proc. Natl. Acad. Sci. U.S.A. 91:1994;8517-8521.
36. Razandi M., Pedram A., Greene G.L., Levin E.R. Cell membrane and nuclear estrogen receptors (ERs) originate from a single transcript: studies of ERα and ERβ expressed in Chinese hamster ovary cells. Mol. Endocrinol. 13:1999;307-319.
37. 2+] (i) by 17β-oestradiol in female rat distal colon. Br. J. Pharmacol. 129:2000;1375-1386.
38. Russell K.S., Haynes M.P., Sinha D., Clerisme E., Bender J.R. Human vascular endothelial cells contain membrane binding sites for estradiol, which mediate rapid intracellular signaling. Proc. Natl. Acad. Sci. U.S.A. 97:2000;5930-5935.
39. Kousteni S., Bellido T., Plotkin L.I., O'Brien C.A., Bodenner D.L., Han L., Han K., DiGregorio G.B., Katzenellenbogen J.A., Katzenellenbogen B.S., Roberson P.K., Weinstein R.S., Jilka R.L., Manolagas S.C. Nongenotropic, sex-nonspecific signaling through the estrogen or androgen receptors: dissociation from transcriptional activity. Cell. 104:2001;719-730.
40. Castoria G., Barone M.V., Di Domenico M., Bilancio A., Ametrano D., Migliaccio A., Auricchio F. Non-transcriptional action of oestradiol and progestin triggers DNA synthesis. EMBO J. 18:1999;2500-2510.
41. Marquez D.C., Pietras R.J. Membrane-associated binding sites for estrogen contribute to growth regulation of human breast cancer cells. Oncogene. 20:2001;5420-5430.
42. Cho H., Katzenellenbogen B.S. Synergistic activation of estrogen receptor-mediated transcription by estradiol and protein kinase activators. Mol. Endocrinol. 7:1993;441-452.
43. El-Tanani M.K., Green C.D. Two separate mechanisms for ligand-independent activation of the estrogen receptor. Mol. Endocrinol. 11:1997;928-937.
44. Le Goff P., Montano M.M., Schodin D.J., Katzenellenbogen B.S. Phosphorylation of the human estrogen receptor. Identification of hormone-regulated sites and examination of their influence on transcriptional activity. J. Biol. Chem. 269:1994;4458-4466.
45. Chen D., Pace P.E., Coombes R.C., Ali S. Phosphorylation of human estrogen receptor alpha by protein kinase A regulates dimerization. Mol. Cell. Biol. 19:1999;1002-1015.
46. 2+ stimulation of CREB-dependent transcription and ERK nuclear translocation. Neuron. 21:1998;869-883.
47. Yao H., York R.D., Misra-Press A., Carr D.W., Stork P.J. The cyclic adenosine monophosphate-dependent protein kinase (PKA) is required for the sustained activation of mitogen-activated kinases and gene expression by nerve growth factor. J. Biol. Chem. 273:1998;8240-8247.
48. Chang L., Karin M. Mammalian MAP kinase signalling cascades. Nature. 410:2001;37-40.
49. Kahlert S., Nuedling S., van Eickels M., Vetter H., Meyer R., Grohe C. Estrogen receptor α rapidly activates the IGF-1 receptor pathway. J. Biol. Chem. 275:2000;18447-18453.
50. Migliaccio A., Castoria G., Di Domenico M., de Falco A., Bilancio A., Lombardi M., Barone M.V., Ametrano D., Zannini M.S., Abbondanza C., Auricchio F. Steroid-induced androgen receptor-oestradiol receptor β-Src complex triggers prostate cancer cell proliferation. EMBO J. 19:2000;5406-5417.
51. Song R.X., McPherson R.A., Adam L., Bao Y., Shupnik M., Kumar R., Santen R.J. Linkage of rapid estrogen action to MAPK activation by ERα-Shc association and Shc pathway activation. Mol. Endocrinol. 16:2002;116-127.
52. Kato S., Endoh H., Masuhiro Y., Kitamoto T., Uchiyama S., Sasaki H., Masushige S., Gotoh Y., Nishida E., Kawashima H.et al. Activation of the estrogen receptor through phosphorylation by mitogen-activated protein kinase. Science. 270:1995;1491-1494.
53. Lopez G.N., Turck C.W., Schaufele F., Stallcup M.R., Kushner P.J. Growth factors signal to steroid receptors through mitogen-activated protein kinase regulation of p160 coactivator activity. J. Biol. Chem. 276:2001;22177-22182.
54. Font de Mora J., Brown M. AIB1 is a conduit for kinase-mediated growth factor signaling to the estrogen receptor. Mol. Cell. Biol. 20:2000;5041-5047.
55. Webb P., Lopez G.N., Uht R.M., Kushner P.J. Tamoxifen activation of the estrogen receptor/AP-1 pathway: potential origin for the cell-specific estrogen-like effects of antiestrogens. Mol. Endocrinol. 9:1995;443-456.
56. Filardo E.J., Quinn J.A., Bland K.I., Frackelton A.R. Jr. Estrogen-induced activation of Erk-1 and Erk-2 requires the G protein-coupled receptor homolog, GPR30, and occurs via trans-activation of the epidermal growth factor receptor through release of HB-EGF. Mol. Endocrinol. 14:2000;1649-1660.